<DOC>
	<DOC>NCT00445094</DOC>
	<brief_summary>The primary objective of this study is a comparison between MK0787B and standard therapy.</brief_summary>
	<brief_title>A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Greater than 18 years of age Patient is diagnosed with nosocomial pneumonia Immunological deficient patients Pregnant women and nursing mothers A fungus is identified before the study enrollment Received vancomycin or imipenem for more than 5 days before icu admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>